期刊文献+

奥曲肽对胰十二指肠切除术后并发症的防治及其机制探讨 被引量:1

The Preventive Effect of Octreotide on Postoperative Complications of Pancreaticoduodenectomy
下载PDF
导出
摘要 目的 探讨奥曲肽 (Outreotide)对胰十二指肠切除术后并发症的防治作用及机制。方法 胰十二指肠切除术患者 96例 ,随机分为两组 :( 1)治疗组 :5 8例 ;( 2 )对照组 :38例。在综合治疗的基础上 ,治疗组加用奥曲肽皮下注射 ,对照组加用洛赛克加 5 %葡萄糖静脉推注 ,两组疗程均为 7~ 10d ,并观察两组病人术后 1周内平均每日消化液引流量以及术后严重并发症的情况。结果 两组病人术后 1周内平均每日消化液引流量 :治疗组 :胰液 ( 5 3± 8)ml,胆汁 ( 172± 2 7)ml,胃液 ( 2 12± 39)ml;对照组 :胰液 ( 2 6 8± 4 6 )ml,胆汁 ( 385± 5 2 )ml,胃液 ( 318± 6 0 )ml,两组相比较 ,治疗组低于对照组 ,有显著性差异 (P <0 .0 1)。术后严重并发症发生率 :治疗组为 14 % ( 8/ 5 8) ,对照组为37% ( 14 / 38) ,两组相比较 ,治疗组低于对照组 ,有显著性差异 (P <0 .0 1) ;术后胰瘘 :治疗组为 3例 (占 5 .2 % ) ,对照组为 7例 (占 18.4 % ) ,两组相比较 ,有显著性差异 (P <0 .0 5 )。死亡 5例 :其中治疗组 1例 ,对照组 4例。结论 奥曲肽可明显减少消化液的分泌量 。 Objective To explore the preventive effect of octreotide on the postoperative complications of pancreaticoduodenectomy.Methods From Jan 1990 to December 2002 patients undergoing pancreaticoduodedectomy were divided into octreotido group( n =58) and control group( n =38).The daily digestive juice output and the severe complications were retrospectively analyzed.Results The daily digestive juice output in octreotide group within one week Was:pancreatic juice of(53±8)ml,bile(172±27)ml and gastric juice(212±39)ml v.s of(268±46)ml,(385±52)ml,and(318±60)ml in the control group(all P <0.01);The incidence of severe complications in octreotide group was 14% vs 37% in the control(χ 2=6.90, P <0.01).The mortality rate in octreotide group was 2% vs.10% in the control group.Conclusion Octreotide effectively prevents or decreases the incidence of severe complications after pancreaticoduodenectomy.
出处 《江西医学院学报》 2003年第4期58-60,共3页 Acta Academiae Medicinae Jiangxi
关键词 胰十二指肠切除术 奥曲肽 并发症 预防 治疗 pancreatoduodenectomy outreotide complications preventive and therapy
  • 相关文献

参考文献3

二级参考文献1

  • 1Bernard Launois,Christian Stasik,Eustathios Bardaxoglou,Bernard Meunier,Jean Pierre Campion,Luigi Greco,Francis Sutherland. Who Benefits from Portal Vein Resection during Pancreaticoduodenectomy for Pancreatic Cancer?[J] 1999,World Journal of Surgery(9):926~929

共引文献45

同被引文献15

  • 1McKay A, Mackenzie S, Sutherland FR, et al.Meta-analysis of pan- creaticojejunostomy versus pancreaticogastrostomy reconstruction after pancreaticoduodeneetomy[J]. Br J Surg, 2006,93(8):929-936.
  • 2Butturini G, Daskalaki D, Molinari E, et al. Pancreatic fistuia: defini- tion and current problems[J]. J Hepatobiliary Pancreat Surg, 2008,15: 247-251.
  • 3Buchler MW, Binder M, Friess H. Role of somatostatin and its ana- logues in the treatment of acute and chronic pancreatitis[.J]. Gut, 1994, 35 (Suppl3):S15-19.
  • 4Buchler MW, Friess H, Klempa I, et al . Role of octreotide in the prevention of postoperative complications following pancreatic re- section[J]. Am J Surg, 1992,163(1 ):125-130.
  • 5刘威,苗雄鹰,李永国,等.静脉输注奥曲肽预防胰十二指肠术后胰瘘[J].中华普通外科杂志,2004,13(12):927-929.
  • 6Klempa I, Baca I, Menzel J, Schuszdiarra V. Effect of somatostatin on basal and stimulated exocrine pancreatic secretion after partial duodenopancreatectomy. A clinical experimental study[J]. Chirurg 1991,62 (4) :293 -299.
  • 7Beguiristain A, Espi A, Balen E, et,al. Somatostatin prophylaxis fol- lowing cephalic duodenopancreatectomy[J]. Rev Esp Enferm Dig, 1995,87 (3):221-224.
  • 8Lowy AM, Lee JE, Pisters PW,et al.Prospective, randomized trial of octreotide to prevent pancreatic fistula after pancreaticoduodenecto- my for malignant disease[J]. Ann Surg, 1997 Nov,226(5):632-41.
  • 9Briceno Delgado FJ, L6pez Cillero P, Rufi6n Pena S, et al. Prospective and randomized study on the usefulness of octreotide in the prevention of complications after cephalic duodeno-pancreatec- tomy[J]. Rev Esp Enferm Dig, 1998,90(10):687-694.
  • 10Yeo C J, Cameron JL, Lillemoe KD, et al. Does prophylactic oc- treotide decrease the rates of pancreatic fistula and other compli- cations after pancreaticoduodenectomy Results of a prospective randomized placebo-controlled trial[J]. Ann Surg, 2000,232 (2) : 419-429.

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部